See All Slides - tctmd.com

Slides

Presentation TCT 2012

Pathogenesis of Vulnerable Plaque 2012: What's New?

Presenter: Renu Virmani

October 23, 2012

Presentation TCT 2012

TCT-34. ABSORB EXTEND: An Interim Report on the 12-month Clinical Outcomes from the First 250 Patients Enrolled

Presenter: Antonio Bartorelli

October 23, 2012

Presentation TCT 2012

Debate II. Is Straight-Line Flow to the Foot Sufficient (And Is the Angiosome Concept Nonsense)? Con!

Presenter: Andrej Schmidt

October 23, 2012

Presentation TCT 2012

First-in-Man Results with a Myolimus-Eluting Bioabsorbable PLLA-based Vascular Scaffold (Elixir DESolve)

Presenter: Stefan Verheye

October 23, 2012

Presentation TCT 2012

TCT-38. Two-year Clinical Data of Cohort 1 and Multi-modality Imaging Results Up to 1-year Follow-up of the BIOSOLVE-I Study with the Paclitaxel-eluting Bioabsorbable...

Presenter: Michael Haude

October 23, 2012

Presentation TCT 2012

Is Ischemia a Marker of Plaque Vulnerability and Future Thrombosis?

Presenter: Bernard De Bruyne

October 23, 2012

Presentation TCT 2012

New Insights into Normal and Diseased Mitral Valve Anatomy

Presenter: David Adams

October 23, 2012

Presentation TCT 2012

TCT-5. Efficacy of Cardiatis Multilayer Flow Modulator in Peripheral and Visceral Aneurysms Repair: Italian Multicenter Registry Results at One Year Follow Up

Presenter: Maria Antonella Ruffino

October 23, 2012

Presentation TCT 2012

Case 1: During a TAVR

Presenter: Susheel Kodali

October 23, 2012

Presentation TCT 2012

TCT-51. Comparison of Clopidogrel and Prasugrel in Patients with Unprotected Left main Disease Treated with Everolimus-eluting Stents: Insight from the Florence Left Main-PCI...

Presenter: Renato Valenti

October 23, 2012

Advertisement

Slides

Pathogenesis of Vulnerable Plaque 2012: What's New?

TCT-34. ABSORB EXTEND: An Interim Report on the 12-month Clinical Outcomes from the First 250 Patients Enrolled

Debate II. Is Straight-Line Flow to the Foot Sufficient (And Is the Angiosome Concept Nonsense)? Con!

First-in-Man Results with a Myolimus-Eluting Bioabsorbable PLLA-based Vascular Scaffold (Elixir DESolve)

TCT-38. Two-year Clinical Data of Cohort 1 and Multi-modality Imaging Results Up to 1-year Follow-up of the BIOSOLVE-I Study with the Paclitaxel-eluting Bioabsorbable...

Is Ischemia a Marker of Plaque Vulnerability and Future Thrombosis?

New Insights into Normal and Diseased Mitral Valve Anatomy

TCT-5. Efficacy of Cardiatis Multilayer Flow Modulator in Peripheral and Visceral Aneurysms Repair: Italian Multicenter Registry Results at One Year Follow Up

Case 1: During a TAVR

TCT-51. Comparison of Clopidogrel and Prasugrel in Patients with Unprotected Left main Disease Treated with Everolimus-eluting Stents: Insight from the Florence Left Main-PCI...

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content